ClinicalTrials.Veeva

Menu

Quality of Life After Laparoscopic Removal of Essure® (ABLIMCO)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Contraceptive Device; Complications
Quality of Life

Treatments

Other: Quality of life after Essure® removal

Study type

Observational

Funder types

Other

Identifiers

NCT03281564
69HCL17_0479

Details and patient eligibility

About

A lot of patients seem to complain after hysteroscopic tubal occlusion by Essure® device with a worce quality of life. Investigators' hypothesis is that Essure® laparoscopic removal may improve quality of life. This prospectice study aim to assess the quality of life 1, 3, 6 and 12 months after Essure® removal.

Enrollment

474 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women aged 18 years or more
  • patients with Essure® sterilization device
  • surgical removal of Essure® with bilateral salpingectomy by laparoscopy

Exclusion criteria

  • interview revealing disorder entailing unacceptable risk of postoperative complications: coagulation disorder, immune system disorder, evolutive disease, etc.
  • impaired lower-limb range of motion preventing positioning for surgery
  • inability to understand information provided
  • prisoner or under administrative supervision.

Trial design

474 participants in 1 patient group

Essure®
Description:
Patients with laparoscopic removal of Essure®
Treatment:
Other: Quality of life after Essure® removal

Trial contacts and locations

1

Loading...

Central trial contact

Gautier CHENE, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems